Objective: Prescription opioids account for 40% of all U.S. opioid overdose deaths, and national efforts have intensified to reduce opioid prescriptions. However, little is known about the relationship between peripheral arterial disease (PAD) and high-risk opioid use. The objectives of this study were to evaluate the relationship between PAD and high opioid use and to assess whether PAD treatment has an impact on high opioid use.
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Objective: Clinical differentiation of buttock claudication from pseudoclaudication (neuromuscular etiology) is often challenging, and it cannot be diagnosed noninvasively using standard ankle-brachial index with exercise. The aim of this study was to evaluate the reliability of exercise transcutaneous oximetry (ExTcPO 2 ) to accurately detect significant internal iliac artery (IIA) inflow stenosis.
Methods: Data from a prospectively maintained registry of consecutive patients undergoing ExTcPO 2 for evaluation of buttock and hip exertional discomfort as well as arterial imaging within 12 months were retrospectively analyzed. ExTcPO 2 was performed on a treadmill (10% slope; 2 mph speed), measured at buttocks, upper back, and calf (rest, with exercise) to document the baseline normal, degree of change with exercise, and recovery patterns. A Delta from Resting Oxygen Pressure (DROP; buttock-back TcPO 2 ) À15 mm Hg was considered significant. A blinded physician performed aortoiliac arterial stenosis quantification, and receiver operating characteristic curve analysis was used to determine sensitivity and specificity to diagnose severe inflow reduction (70%) based on a diagnostic DROP À15 mm Hg.
Results: There were 111 patients (male/female, 79/32; mean age, 70 years; range, 18-90 years) with available concomitant imaging (computed tomography angiography, 90; duplex ultrasound, 21) included in the study. Indications for testing were suspected vascular (82) or neuromuscular (29) symptoms. ExTcPO 2 study confirmed the clinical suspicion of the state of IIA inflow in 81% (91/111) of patients. DROP À15 mm Hg had a sensitivity, specificity, positive predictive value, and negative predictive value of 56%, 80%, 70%, and 68%, respectively, for prediction of severe IIA inflow reduction (P < .001; odds ratio, 1.107; 95% confidence interval, 1.066-1.150; C statistic, 0.73; standard error, 0.03; Fig 1) . Aortoiliac arterial reconstruction to treat severe IIA flow compromise was performed in 21 patients. Revascularization was direct antegrade in 17 patients (IIA percutaneous transluminal angioplasty/stenting, 6; aortoiliac stenting/endarterectomy, 11), direct retrograde (aortobi-iliac bypass) in 1, and indirect by increased collateral flow (profundaplasty) in 3. Postoperatively, symptom relief was noted in 20 of 21 patients and objectively demonstrated on ExTcPO 2 in 6 of 7 (Fig 2) . One patient did not improve clinically or on ExTcPO 2 after indirect revascularization. Conclusions: ExTcPO 2 can reliably diagnose significant IIA inflow stenosis. It is simple and noninvasive and can serve as a valuable screening tool to differentiate buttock claudication from other neuromuscular causes of low back, buttock, and hip discomfort as well as to confirm adequacy of aortoiliac revascularization postoperatively in conjunction with standard, noninvasive vascular evaluation with ankle-brachial index.
Author Disclosures: W. Harmsen: Nothing to disclose; M. Kalra: Nothing to disclose; D. Liedl: Nothing to disclose; G. Mahe: Nothing to disclose; I. Sen: Nothing to disclose; P. Wennberg: Nothing to disclose. Objective: A fragmented health care system contributes to suboptimal resource utilization and care coordination. A Care Delivery Redesign (CDR) for the vascular surgery service was developed to improve diagnosis-related group (DRG) assignment, to decrease length of stay (LOS), and to minimize care variation through standardized care pathways. We measured the value of CDR through hospital financial metrics.
Methods: The CDR consisted of a physician champion, inpatient nurse practitioner, and dedicated case manager. The vascular surgery nurse practitioner played a central role in CDR by facilitating all aspects of patient care coordination, resident education, and communication with hospital coding specialists. A real-time weekly inpatient tracker was created and reviewed weekly during vascular conference. The tracker contains patient identifier, admission and discharge date, attending, admission and discharge unit, current LOS, Centers for Medicare and Medicaid Services geometric mean LOS, and corresponding DRG. Tools created to track performance and to ensure sustainability included daily discussions of barriers and solutions on patient rounds, creation of a vascular surgery mobile app for residents, and a patient avoidable delay tracker. End points included LOS, total variable cost, case mix index, and vascular surgery contribution margin compared with pre-CDR contribution margin.
Results: Implementation of CDR resulted in a 23% decrease in LOS, reducing the gap to Centers for Medicare and Medicaid Services geometric mean LOS by 1.6 days, from 2.2 days to 0.5 day. Improvement and changes in documentation captured accurate DRGs, which resulted in an increase in case mix index of 21%. This resulted in contribution margin amounting to $1.88 million.
Conclusions: The CDR structure as described reduces hospital LOS and improves financial service metrics. The structure is predicated on a dedicated service line advanced practitioner, weekly service tracker review, and real-time management of barriers and solutions to system-related issues. As designed, CDR provided significant financial benefit to the hospital while facilitating patient care.
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